NVZMY - Novozymes A/S

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in DKK. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue14,390,00014,531,00014,142,00014,002,000
Cost of Revenue6,089,0006,103,0005,976,0005,699,000
Gross Profit8,301,0008,428,0008,166,0008,303,000
Operating Expenses
Research Development1,852,0001,901,0001,865,0001,896,000
Selling General and Administrative2,345,0002,450,0002,432,0002,447,000
Non Recurring----
Others-43,000-63,000-117,000-98,000
Total Operating Expenses10,232,00010,411,00010,138,0009,959,000
Operating Income or Loss4,158,0004,120,0004,004,0004,043,000
Income from Continuing Operations
Total Other Income/Expenses Net-222,000-244,000-123,000-422,000
Earnings Before Interest and Taxes4,158,0004,120,0004,004,0004,043,000
Interest Expense-13,000-27,000-31,000-31,000
Income Before Tax3,936,0003,876,0003,881,0003,621,000
Income Tax Expense709,000756,000831,000796,000
Minority Interest13,00013,00013,00013,000
Net Income From Continuing Ops3,227,0003,120,0003,050,0002,825,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income3,226,0003,119,0003,050,0002,823,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares3,226,0003,119,0003,050,0002,823,000